Dover Intelligent Bio-Systems, Dover, Azco Partner to Launch Max-Seq Low-Cost Short-Read Sequencer Premium By Julia Karow This article has been updated to correct the spelling of Jingyue Ju's name. Dover's Polonator Unaffected by Danaher's Restructuring, Official Says Premium The company shipped its tenth Polonator last month and has several pending orders, according to a Dover official. Azco Biotech Becomes Value-Added Reseller for Dover/Church Polonator Premium Azco will provide pre- and post-sales support, start-up reagents, applications support, on-site installation, user training, on-site warranty support, and ongoing technical support, which will increase the price of the platform. Breaking News High-Throughput Testing Reveals Genetic Programs, Pathogenic Variants in Neurodegenerative Disease SpIntellx, ICura Strike Precision Cancer Medicine Partnership Genapsys Founders Lose Bid to Dismiss Bankruptcy Case Autism Spectrum Disorder Studies Uncover Additional Genetic Risk Variants QuidelOrtho Board Authorizes $300M Share Repurchase The Scan Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study. New Insights Into TP53-Driven Cancer Researchers examine in Nature how TP53 mutations arise and spark tumor development. Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer. Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.